CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Vancouver, Washington, United States and 125 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Salem, Oregon, United States and 50 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Portland, Oregon, United States and 26 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Portland, Oregon, United States and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Vancouver, Washington, United States and 215 other locations
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Phase 2
Portland, Oregon, United States and 29 other locations
T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose-escalation (Part A) and...
Phase 1
Portland, Oregon, United States and 13 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Portland, Oregon, United States and 140 other locations
by the intravenous (IV) route to participants with solid tumors or lymphomas.The main goals of this study are to:Find the recommended dose o...
Phase 1, Phase 2
Portland, Oregon, United States and 9 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Portland, Oregon, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal